239 related articles for article (PubMed ID: 33128786)
1. Ultrasonography-guided radiofrequency ablation vs. surgery for the treatment of solitary T1bN0M0 papillary thyroid carcinoma: A comparative study.
Xiao J; Zhang Y; Zhang M; Lan Y; Yan L; Luo Y; Tang J
Clin Endocrinol (Oxf); 2021 Apr; 94(4):684-691. PubMed ID: 33128786
[TBL] [Abstract][Full Text] [Related]
2. Comparison of ultrasound-guided radiofrequency ablation versus thyroid lobectomy for T1bN0M0 papillary thyroid carcinoma.
Yan L; Li X; Li Y; Xiao J; Zhang M; Luo Y
Eur Radiol; 2023 Jan; 33(1):730-740. PubMed ID: 35895122
[TBL] [Abstract][Full Text] [Related]
3. Ultrasonography-guided radiofrequency ablation for solitary T1aN0M0 and T1bN0M0 papillary thyroid carcinoma: a retrospective comparative study.
Xiao J; Zhang Y; Yan L; Zhang M; Li X; Tang J; Luo Y
Eur J Endocrinol; 2021 Dec; 186(1):105-113. PubMed ID: 34757942
[TBL] [Abstract][Full Text] [Related]
4. [Short-term Outcome of T1bN0M0 Papillary Thyroid Cancer after Ultrasonography-guided Radiofrequency Ablation].
Xiao J; Lan Y; Yan L; Zhang MB; Zhang Y; Xie F; Song Q; Luo YK; Tang J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Dec; 42(6):771-775. PubMed ID: 33423724
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound-Guided Radiofrequency Ablation
He H; Wu R; Zhao J; Song Q; Zhang Y; Luo Y
Front Endocrinol (Lausanne); 2021; 12():734432. PubMed ID: 34512557
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound-guided microwave ablation versus surgery for solitary T1bN0M0 papillary thyroid carcinoma: a prospective multicenter study.
Guo MH; Dou JP; Zheng L; Liu FY; Yu J; Cheng ZG; Yu XL; Che Y; Wang SR; Cong ZB; Bai N; Liu C; Hao Y; Yu MA; Xu ZF; Han ZY; Liang P; Chen L
Eur Radiol; 2024 Jan; 34(1):569-578. PubMed ID: 37548692
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of ultrasonography-guided radiofrequency ablation for the treatment of T1bN0M0 papillary thyroid carcinoma: a retrospective study.
Xiao J; Zhang M; Zhang Y; Yan L; Lan Y; Zhu Y; Zhang Y; Lin L; Tang J; Luo Y
Int J Hyperthermia; 2020; 37(1):392-398. PubMed ID: 32340500
[No Abstract] [Full Text] [Related]
8. Clinical outcomes of ultrasound-guided radiofrequency ablation for solitary T1N0M0 papillary thyroid carcinoma: A retrospective study with more than 5 years of follow-up.
Yan L; Li Y; Li XY; Xiao J; Tang J; Luo Y
Cancer; 2023 Aug; 129(16):2469-2478. PubMed ID: 37060239
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of radiofrequency ablation for solitary T1aN0M0 versus T1bN0M0 papillary thyroid carcinoma: a propensity-matched cohort study.
Tong M; Wang L; Gai Z; Zhu Y; Che Y
Int J Hyperthermia; 2023; 40(1):2257908. PubMed ID: 37848402
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation for solitary T1N0M0 papillary thyroid carcinoma in the danger triangle area: a preliminary analysis.
Zhang DL; Chen S; Qiu Y; Yang JC; Hong Z; Li J; Wu SS
Int J Hyperthermia; 2024; 41(1):2305256. PubMed ID: 38314684
[TBL] [Abstract][Full Text] [Related]
11. Ultrasonography-guided radiofrequency ablation for the treatment of T2N0M0 papillary thyroid carcinoma: a preliminary study.
Xiao J; Zhang Y; Zhang M; Xie F; Yan L; Luo Y; Tang J
Int J Hyperthermia; 2021; 38(1):402-408. PubMed ID: 33719861
[TBL] [Abstract][Full Text] [Related]
12. Surgery After Ultrasound-Guided Radiofrequency Ablation for Papillary Thyroid Carcinoma in 21 Patients: A Retrospective Study from a Single Center in China.
Sun W; Zhang H; He L; Zhang T; Wang Z; Dong W; Jiang Y
Med Sci Monit; 2020 Nov; 26():e928391. PubMed ID: 33221812
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of radiofrequency ablation for treating locoregional recurrence from papillary thyroid cancer.
Lim HK; Baek JH; Lee JH; Kim WB; Kim TY; Shong YK; Hong SJ
Eur Radiol; 2015 Jan; 25(1):163-70. PubMed ID: 25199815
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound-Guided Radiofrequency Ablation Versus Surgery for Low-Risk Papillary Thyroid Microcarcinoma: Results of Over 5 Years' Follow-Up.
Zhang M; Tufano RP; Russell JO; Zhang Y; Zhang Y; Qiao Z; Luo Y
Thyroid; 2020 Mar; 30(3):408-417. PubMed ID: 31910107
[No Abstract] [Full Text] [Related]
15. Efficacy and Safety of Thermal Ablation for Solitary T1bN0M0 Papillary Thyroid Carcinoma: A Multicenter Study.
Cao XJ; Liu J; Zhu YL; Qi L; Liu G; Wang HL; Wang ZH; Zhou Y; He JF; Guo JQ; Shi LL; Jian M; Shataer A; Yan GZ; Zhao ZL; Wei Y; Peng LL; Li Y; Che Y; Wang SR; Yu MA
J Clin Endocrinol Metab; 2021 Jan; 106(2):e573-e581. PubMed ID: 33107573
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of ultrasound-guided radiofrequency, microwave and laser ablation for the treatment of T1N0M0 papillary thyroid carcinoma on a large scale: a systematic review and meta-analysis.
Gao X; Yang Y; Wang Y; Huang Y
Int J Hyperthermia; 2023 Dec; 40(1):2244713. PubMed ID: 37604507
[TBL] [Abstract][Full Text] [Related]
17. Rigorous radiofrequency ablation can completely treat low-risk small papillary thyroid carcinoma without affecting subsequent surgical management.
Li X; Li J; Qiao Z; Yan L; Xiao J; Li Y; Zhang M; Luo Y
Eur Radiol; 2023 Jun; 33(6):4189-4197. PubMed ID: 36538070
[TBL] [Abstract][Full Text] [Related]
18. Ultrasonography-Guided Thermal Ablation for Cervical Lymph Node Metastasis of Recurrent Papillary Thyroid Carcinoma: Is it Superior to Surgical Resection?
Zhang X; Ni T; Zhang W
Front Endocrinol (Lausanne); 2022; 13():907195. PubMed ID: 35832431
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Outcomes and Risk Factors of Radiofrequency Ablation for T1N0M0 Papillary Thyroid Carcinoma.
Li X; Yan L; Xiao J; Li Y; Yang Z; Zhang M; Luo Y
JAMA Surg; 2024 Jan; 159(1):51-58. PubMed ID: 37878294
[TBL] [Abstract][Full Text] [Related]
20. Sonographic Evolution and Pathologic Findings of Papillary Thyroid Cancer After Radiofrequency Ablation: A Five-Year Retrospective Cohort Study.
Li X; Li Y; Yan L; Xiao J; Yang Z; Jing H; Zhang M; Luo Y
Thyroid; 2024 Jan; 34(1):54-63. PubMed ID: 37885207
[No Abstract] [Full Text] [Related]
[Next] [New Search]